The Combination of Olaparib and Camptothecin for Effective Radiosensitization

Radiation Oncology- United Kingdom

doi 10.1186/1748-717x-7-62

Full Text

Abstract

Available in

Categories

Nuclear Medicine

Date

January 1, 2012

Authors

Katsutoshi Miura

Koh-ichi Sakata

Masanori Someya

Yoshihisa Matsumoto

Hideki Matsumoto

Akihisa Takahashi

Masato Hareyama

Publisher

Springer Science and Business Media LLC

Related search

Nanoparticles for Effective Combination Therapy of Cancer

International Journal of Nanotechnology and Nanomedicine

English

Preclinical Evaluation of the PARP Inhibitor, Olaparib, in Combination With Cytotoxic Chemotherapy in Pediatric Solid Tumors

Pediatric Blood and Cancer

English

Characterization of DNA Topoisomerase-1 in Spodoptera Exigua for Toxicity Evaluation of Camptothecin and Hydoxy-Camptothecin

Multidisciplinary

English

ATM-deficient Lung, Prostate and Pancreatic Cancer Cells Are Acutely Sensitive to the Combination of Olaparib and the ATR Inhibitor AZD6738

Genome Instability & Disease

English

Valuable and Cost Effective Combination of Cd123 and Cd22 for Basophil Discrimination

International Journal of Medical Laboratory Research

English

Ultrasound Hyperthermia Technology for Radiosensitization

Ultrasound in Medicine and Biology

Ultrasound Technology

Nuclear Medicine

English

Olaparib and Temozolomide in Desmoplastic Small Round Cell Tumors: A Promising Combination in Vitro and in Vivo

Journal of Cancer Research and Clinical Oncology

Cancer Research

English

Enhancement of the Antitumor Effect of .GAMMA.-Ray Irradiation in Combination With Camptothecin Against Human Colorectal Adenocarcinoma.

Biological and Pharmaceutical Bulletin

Pharmaceutical Science

English

Phase I Study to Assess the Safety and Tolerability of Olaparib in Combination With Bevacizumab in Patients With Advanced Solid Tumours

British Journal of Cancer

Cancer Research

English